Bioscientia Institute for Medical Diagnostics GmbH


The Bioscientia Institute is an internationally active laboratory diagnostics company under medical leadership located in Ingelheim am Rhein. The company was founded in 1970 by Boehringer Ingelheim and has since 1995 been managed as an independent company. Since 2007 Bioscientia is part of the Sonic Healthcare Group, a worldwide association of outstanding laboratory diagnostic companies with locations in Australia, New Zealand, Germany, Great Britain, Belgium, Ireland, Switzerland and the USA.

Based on a modern industrial organization, Bioscientia has been one of the leading medical diagnostic laboratories in Europe for many years. The range covers a broad spectrum from the fields of laboratory medicine, microbiology and human genetics. With over 20 laboratories, Bioscientia guarantees a comprehensive, high-quality supply of modern laboratory medicine.

Bioscientia employs more than 1,600 people who serve customers from a wide variety of fields. These include more than 8,000 physicians and institutional customers at the local and international level, including clinics, universities, health authorities and pharmaceutical companies, as well as diagnostics manufacturers.

Bioscientia's roots in the pharmaceutical industry are now more relevant than ever:  Bioscientia has been supporting R&D projects as an integral part of its service portfolio for decades with a dedicated, professional team for pharma as well diagnostic R&D projects. With the increasing importance of diagnostics in healthcare, via diagnostics2market Bioscientia offers a service that effectively supports diagnostics manufacturers in the development, approval and surveillance of high-quality and innovative diagnostics.